Hidemaru Yamaguchi
Stock Analyst at Citi
(1.37)
# 3,544
Out of 4,501 analysts
62
Total ratings
52.4%
Success rate
-0.7%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Maintained: Sell | ¥1,260 → ¥1,500 | $1,413.00 | +6.16% | 5 | May 25, 2026 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Hold | ¥2,500 → ¥2,400 | $2,147.50 | +11.76% | 3 | May 1, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | $2,839.50 | -1.39% | 1 | Apr 3, 2026 | |
| TYO: 4587 PeptiDream Inc. | Downgraded: Hold | ¥3,300 → ¥1,600 | $1,022.50 | +56.48% | 2 | Mar 12, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | $2,637.50 | -24.17% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Buy | ¥2,600 → ¥2,800 | $1,874.00 | +49.41% | 6 | Feb 9, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥5,800 → ¥4,900 | $2,751.50 | +78.08% | 6 | Feb 5, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Maintained: Hold | ¥600 → ¥670 | $476.00 | +40.76% | 4 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Maintained: Buy | ¥1,100 → ¥1,400 | $922.00 | +51.84% | 5 | Nov 28, 2025 | |
| TYO: 4523 Eisai Co., Ltd. | Maintained: Buy | ¥5,900 → ¥6,200 | $4,310.00 | +43.85% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,800 → ¥3,900 | $2,191.50 | +77.96% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,200 → ¥3,500 | $3,596.00 | -2.67% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥1,750 | $2,433.50 | -28.09% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥10,400 → ¥10,500 | $11,155.00 | -5.87% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,100 → ¥4,600 | $4,088.00 | +12.52% | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,600 | $2,134.00 | +21.84% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,200 → ¥3,500 | $4,035.00 | -13.26% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,410 | $2,636.00 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥960 | $1,047.00 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | $2,274.00 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥12,000 | $7,368.00 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,100 → ¥2,800 | $2,836.50 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,300 | $1,537.50 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $29.65 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $25.48 | n/a | 1 | Nov 18, 2009 |
Sumitomo Pharma Co., Ltd.
May 25, 2026
Maintained: Sell
Price Target: ¥1,260 → ¥1,500
Current: $1,413.00
Upside: +6.16%
Astellas Pharma Inc.
May 1, 2026
Maintained: Hold
Price Target: ¥2,500 → ¥2,400
Current: $2,147.50
Upside: +11.76%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: $2,839.50
Upside: -1.39%
PeptiDream Inc.
Mar 12, 2026
Downgraded: Hold
Price Target: ¥3,300 → ¥1,600
Current: $1,022.50
Upside: +56.48%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: $2,637.50
Upside: -24.17%
M3, Inc.
Feb 9, 2026
Maintained: Buy
Price Target: ¥2,600 → ¥2,800
Current: $1,874.00
Upside: +49.41%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Maintained: Buy
Price Target: ¥5,800 → ¥4,900
Current: $2,751.50
Upside: +78.08%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Maintained: Hold
Price Target: ¥600 → ¥670
Current: $476.00
Upside: +40.76%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Maintained: Buy
Price Target: ¥1,100 → ¥1,400
Current: $922.00
Upside: +51.84%
Eisai Co., Ltd.
Sep 12, 2025
Maintained: Buy
Price Target: ¥5,900 → ¥6,200
Current: $4,310.00
Upside: +43.85%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,800 → ¥3,900
Current: $2,191.50
Upside: +77.96%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,200 → ¥3,500
Current: $3,596.00
Upside: -2.67%
Aug 28, 2025
Maintained: Hold
Price Target: ¥1,750
Current: $2,433.50
Upside: -28.09%
Aug 27, 2025
Maintained: Buy
Price Target: ¥10,400 → ¥10,500
Current: $11,155.00
Upside: -5.87%
Aug 26, 2025
Maintained: Buy
Price Target: ¥5,100 → ¥4,600
Current: $4,088.00
Upside: +12.52%
Aug 22, 2025
Maintained: Buy
Price Target: ¥2,600
Current: $2,134.00
Upside: +21.84%
Aug 22, 2025
Maintained: Buy
Price Target: ¥4,200 → ¥3,500
Current: $4,035.00
Upside: -13.26%
Jun 26, 2025
Maintained: Hold
Price Target: ¥2,410
Current: $2,636.00
Upside: n/a
Jun 26, 2025
Maintained: Hold
Price Target: ¥960
Current: $1,047.00
Upside: n/a
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: $2,274.00
Upside: n/a
May 27, 2025
Maintained: Buy
Price Target: ¥12,000
Current: $7,368.00
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ¥3,100 → ¥2,800
Current: $2,836.50
Upside: n/a
Nov 26, 2024
Maintained: Hold
Price Target: ¥3,300
Current: $1,537.50
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $29.65
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $25.48
Upside: n/a